enteroporc coli ac
ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - pigs - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:- clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6- clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins- clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin
neocolipor each 2 ml (dose) contains: escherichia coli k12 (f4ab, f4ac, f4ad factor antigen) escherichia coli k12 (f5 factor antigen) escherichia coli 09 (k9 factor antigen) escherichia coli 0101 (f41 factor antigen) >2.1 sau.* 21.7 sa u.* 21.4 sa u.* 21.7 sa u.* "i sau: .s. to obtain a seroagglutinating antibody titre of 1 log10 inguine pigs suspension for injection (im)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated escherichia coli fimbrial adhesins vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: escherichia coli k12 (f4ab, f4ac, f4ad factor antigen) escherichia coli k12 (f5 factor antigen) escherichia coli 09 (k9 factor antigen) escherichia coli 0101 (f41 factor antigen) >2.1 sau.* 21.7 sa u.* 21.4 sa u.* 21.7 sa u.* "i sau: .s. to obtain a seroagglutinating antibody titre of 1 log10 inguine pigs
suiseng each 2 ml (dose) contains: escherichia coli fimbrial adhesin f4ab f4ac f5 f6 %65% er60 278% er70 279% er 50 >80% er35 >55% er 70 >35% er25 >50% er120 e. coli lt enterotoxoid clotridium perfringens (type c) btoxoid clostridium novyi (type b) a toxoid % erx: percentage of immunized rabbits with enzyme immunoassay response. suspension for injection (im)
hipra philippines inc.; distributor: hipra philippines inc. - inactivated escherichia coli fimbrial adhesin (f4ab, f4ac, f5 and f6) , heat labile (lt) enterotoxoid , clotridium perfringens (type c) b toxoid , clostridium novyi (type b) a toxoid vaccine (vet.) - suspension for injection (im) - each 2 ml (dose) contains: escherichia coli fimbrial adhesin f4ab f4ac f5 f6 %65% er60 278% er70 279% er 50 >80% er35 >55% er 70 >35% er25 >50% er120 e. coli lt enterotoxoid clotridium perfringens (type c) btoxoid clostridium novyi (type b) a toxoid % erx: percentage of immunized rabbits with enzyme immunoassay response.
porcilis porcoli df formulation: each 2 ml (dose) contains: escherichia coli f4ab (k88ab) fimbrial adhesin (k12 strain) . escherichia coli f4ac (k88ac) fimbrial adhesin (k12 strain) escherichia coli f5 (k99) fimbrial adhesin (k12 strain) escherichia coli f6 (987p) fimbrial adhesin (987p-5 strain) escherichia coli lt toxoid (k12 strain) .. u – determinal antigenic mass by elisa (enzyme-lunkei immunosorbent assay) processed under fda memorandum circular 2021-001. ≥ 400 u 120 u ≥ 400 u ≥ 1000 u > 320 ng suspension for injection (im)
msd animal health (phils.), inc. - inactivated escherichia coli fimbrial adhesin , heat labile toxoid (lt) vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: escherichia coli f4ab (k88ab) fimbrial adhesin (k12 strain) . escherichia coli f4ac (k88ac) fimbrial adhesin (k12 strain) escherichia coli f5 (k99) fimbrial adhesin (k12 strain) escherichia coli f6 (987p) fimbrial adhesin (987p-5 strain) escherichia coli lt toxoid (k12 strain) .. u – determinal antigenic mass by elisa (enzyme-lunkei immunosorbent assay) processed under fda memorandum circular 2021-001. ≥ 400 u 120 u ≥ 400 u ≥ 1000 u > 320 ng
entericolix formulation: each 2 ml (dose) contains: escherichia coli, f6 adhesins (p4 strain) ......... 21 rp f18ab adhesins (p5 strain) ....... 2 1 rp f4ac adhesins (p6 strain) 2 1 rp f18ac adhesins (p9 strain) .......... 2 1 rp f5 + f41 adhesins (p10 strain) .... 21 rp clostridium perfringens, type c, b-toxoid (czv13 strain) ............ 2 10 iu rp - relative potency iu - international unit (b-antitoxin per ml of rabbit serum) emulsion for injection (im)
boehringer ingelheim animal health philippines, inc.; distributor: boehringer ingelheim animal health philippines, inc. - inactivated escherichia coli fimbrial adhesins , clostridium perfringens b-toxoid vaccine (vet.) - emulsion for injection (im) - formulation: each 2 ml (dose) contains: escherichia coli, f6 adhesins (p4 strain) ......... 21 rp f18ab adhesins (p5 strain) ....... 2 1 rp f4ac adhesins (p6 strain) 2 1 rp f18ac adhesins (p9 strain) .......... 2 1 rp f5 + f41 adhesins (p10 strain) .... 21 rp clostridium perfringens, type c, b-toxoid (czv13 strain) ............ 2 10 iu rp - relative potency iu - international unit (b-antitoxin per ml of rabbit serum)
porcine pili shield + c each 2 ml (dose) contains: clostridium perfringens (type c) ............ escherichia coli k99 (b44 strain) ...... escherichia coli k99 + f41 (b41 strain) ... escherichia coli k88, (1769 strain) .................. escherichia coli 987p (1592 strain) ............... cpu-colony plate unit od-optical density 2621 cpu 20.53 od 23.7 od 21.8 od 23.8 od solution for injection (im)
elanco philippines, inc.; distributor: elanco philippines, inc. - inactivated clostridium perfringens , escherichia coli vaccine (vet.) - solution for injection (im) - each 2 ml (dose) contains: clostridium perfringens (type c) ............ escherichia coli k99 (b44 strain) ...... escherichia coli k99 + f41 (b41 strain) ... escherichia coli k88, (1769 strain) .................. escherichia coli 987p (1592 strain) ............... cpu-colony plate unit od-optical density 2621 cpu 20.53 od 23.7 od 21.8 od 23.8 od
litterguard lt-c formulation: each (2 ml) dose contains: escherichia coli k99 + f41 adhesin (nadc 1471 strain) ...................>1.36 rp 987p adhesin (nadc 1413 strain) ............................. >1.44 rp k88 adhesin (pps002 strain).................>1.41 rp ltb adhesin(nl-1001 strain) ...................... >1.62 rp k99 adhesin (nl-1005 strain) .................>1.48 rp clostridium perfringens type c antigen (nl-1003 strain) ...........>10 iau rp-relative potency iau-international antitoxin unit suspension for injection (im/sc)
zoetis philippines, inc.; distributor: zoetis philippines, inc. - inactivated escherichia coli fimbrial adhesins , clostridium perfringens vaccine (vet.) - suspension for injection (im/sc) - formulation: each (2 ml) dose contains: escherichia coli k99 + f41 adhesin (nadc 1471 strain) ...................>1.36 rp 987p adhesin (nadc 1413 strain) ............................. >1.44 rp k88 adhesin (pps002 strain).................>1.41 rp ltb adhesin(nl-1001 strain) ...................... >1.62 rp k99 adhesin (nl-1005 strain) .................>1.48 rp clostridium perfringens type c antigen (nl-1003 strain) ...........>10 iau rp-relative potency iau-international antitoxin unit
prosystem® rce formulation: each dose contains: porcine rotavirus, serogroup a (serotype g4 & g5)....... 26.2 login tcid50 escherichia coli (strain 80-2575) k88 21.3 rp (strain nadc 1471) k99.. 21.3 rp (strain nadc 1413) 987p. 1.2 rp (strain nadc 1471) f41.. ≥1.4 rp clostridium perfringens, type c (strain 4407)... ≥10 iau rp relative potency jau – international antitoxin units tcid – tissue culture infectious dose freeze-dried vaccine freeze-dried vaccine. for solution (im)
msd animal health (phils.), inc.; distributor: msd animal health (phils.), inc. - modified live porcine rotavirus , clostridium modified live porcine rotavirus , clostridium perfringens , escherichia coli vaccine (vet.) - freeze-dried vaccine freeze-dried vaccine. for solution (im) - formulation: each dose contains: porcine rotavirus, serogroup a (serotype g4 & g5)....... 26.2 login tcid50 escherichia coli (strain 80-2575) k88 21.3 rp (strain nadc 1471) k99.. 21.3 rp (strain nadc 1413) 987p. 1.2 rp (strain nadc 1471) f41.. ≥1.4 rp clostridium perfringens, type c (strain 4407)... ≥10 iau rp relative potency jau – international antitoxin units tcid – tissue culture infectious dose
inmunair 17.5 formulation: each 1 ml contains: propionibacterium acnes (czv-cmc strain) ................. 0.17 mg escherichia coli lipopolysaccharide.............. 0.05 mg oral suspension
vet specialists, inc.; distributor: vet specialists, inc. - inactivated propionibacterium acnes , escherichia coli lipopolysaccharide (vet.) - oral suspension - formulation: each 1 ml contains: propionibacterium acnes (czv-cmc strain) ................. 0.17 mg escherichia coli lipopolysaccharide.............. 0.05 mg
porcilis porcoli df formulation: each 2 ml (dose) contains: escherichia coli f4ab (k88ab) fimbrial adhesin (k12 strain) ....
n/a; importer: msd animal health (phils.), inc.; distributor: n/a - inactivated escherichia coli fimbrial adhesin , heat labile toxoid (lt) toxoid vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: escherichia coli f4ab (k88ab) fimbrial adhesin (k12 strain) .... > 400 u f4ac (k8